| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $696.5M | +11.5% |
| Cost of Revenue | $342.0M | +6.2% |
| Gross Profit | $354.5M | +17.1% |
| R&D Expense | $143.2M | +4.3% |
| SG&A Expense | $122.9M | +11.6% |
| Operating Income | -$42.3M | +50.9% |
| Pre-tax Income | -$30.9M | +50.1% |
| Income Tax | $7.7M | +115.5% |
| Net Income | -$38.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $358.6M | +56.1% |
| Short-term Investments | $88.1M | -6.7% |
| Accounts Receivable | $42.1M | -1.9% |
| Current Assets | $558.7M | +30.5% |
| Total Assets | $1.29B | +7.8% |
| Current Liabilities | $398.9M | +108.2% |
| Total Liabilities | $777.0M | +3.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $135.8M | +93.1% |
| Capital Expenditures | $6.7M | +18.0% |
| Investing Cash Flow | -$21.1M | -118.6% |
| Financing Cash Flow | $13.3M | +108.8% |
| Free Cash Flow | $129.1M | +99.7% |
| +41.1% |
| EPS (Basic) | -$0.64 | +42.9% |
| EPS (Diluted) | -$0.64 | +42.9% |
| Stockholders' Equity |
| $517.8M |
| +15.5% |